BioSpace News Archive

Business

Mind the talent gap: new biologics facility to upskill future workforce

The opening of a new $11.5m biotech production and training facility at the University of Technology Sydney has been welcomed by government and industry leaders who say fostering and keeping local talent in the burgeoning Life Sciences sector is key to building a globally competitive industry.

July 24, 2019
·
4 min read
Business

Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Business

Double-digit sales growth delivered by Pharma Biotech & Nutrition (LPBN) segment

July 24, 2019
·
16 min read
Business

Horizon Discovery Group plc: Trading Update

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation technologies, provides a trading update for the six month period ended 30 June 2019.

July 24, 2019
·
3 min read
Global BioLife Inc.'s Naturally Modified Sugar Laetose(TM) Unveiled at Harvard Global Health Summit

SGX-listed Singapore eDevelopment Ltd is pleased to announce the results of clinical trials conducted on Laetose, a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc..

July 24, 2019
·
3 min read
Business

Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman

Arcis Biotechnology, the nucleic acid sample preparation solution provider, announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors.

July 24, 2019
·
2 min read
BioCapital

Reston Hospital Center and StoneSprings Hospital Center Recognized For Excellence in Cardiac Care by Healthgrades

Reston Hospital Center and StoneSprings Hospital Center proudly announce that they have been given Five-Star ratings for the Treatment of Heart Failure and Treatment of Heart Attack by Healthgrades for 2019.

July 24, 2019
·
1 min read
Genetown

TScan Closes on Series B to Develop Next-Generation Immuno-Oncology Therapies

The company’s focus is on improving immuno-oncology therapies, making them more effective for the patients for whom these new therapies don’t work and by decreasing serious side effects.

July 24, 2019
·
2 min read
·
Mark Terry
Policy

2019 FDA Warning Letters in the BioPharma Industry So Far

As 2019 enters its second half, BioSpace takes a look at some of the warning letters issued by the U.S. Food and Drug Administration to the biopharma industry.

July 24, 2019
·
6 min read
·
Alex Keown
Policy

Biopharma and Intellectual Property: Protecting One of America’s Great Economic Engines

Patents and intellectual property protections are a big deal in the biopharma industry. One reason is simply the timeline of drugs and therapeutics. Biopharma has several unique challenges, but one of them is the patent cliff.

July 24, 2019
·
5 min read
·
Mark Terry
BioSpace Global Roundup, July 25

Biotech and pharma companies from across the globe provide updates on company strategy and pipeline developments.

July 24, 2019
·
6 min read
·
Alex Keown